Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Busulfan in Pediatric AML HSCT
NCT01274195Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan in acute myeloid leukemia (AML), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
busulfan
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01274195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274195.